The researchers say the technology could eventually support more personalised care, allowing treatments to be better matched ...

Lipoprotein(a), a fatty particle, can clog arteries just as surely as cholesterol but often goes undetected, striking ...

Researchers at the MRC Laboratory of Medical Sciences (LMS) and Imperial College London in London, UK have developed a ...

Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...

A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce ...

Drs Harrington and Gibson’s annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ...

The U.S. Food and Drug Administration has approved Cytokinetics' oral drug to treat a rare heart condition, the company said ...

Officials for the FDA have expanded its’ approval of pimobendan chewable tablets (Vetmedin; Boehringer Ingelheim) to include ...

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by ...

Chevy Chase revealed that he had a near-fatal heart failure that led to a coma and severe memory loss in 2021 in the CNN ...

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...